Thiazolyl urea derivatives as phosphatidylinositol 3-kinase inhibitors

Details for Australian Patent Application No. 2007264033 (hide)

Owner Novartis AG

Inventors Weitz, Schmidt Gabriele; Bruce, Ian

Agent Davies Collison Cave

Pub. Number AU-A-2007264033

PCT Pub. Number WO2008/000421

Priority 0612630.4 26.06.06 GB

Filing date 25 June 2007

Wipo publication date 3 January 2008

International Classifications

A61K 31/4439 (2006.01)

A61P 37/00 (2006.01) Drugs for immunological or allergic disorders

C07D 401/14 (2006.01) Heterocyclic compounds containing two or more hetero rings

C07D 417/14 (2006.01) Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group

Event Publications

15 January 2009 PCT application entered the National Phase

  PCT publication WO2008/000421 Priority application(s): WO2008/000421

7 June 2012 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(e). Examination has been requested or an examination report has issued for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2007264041-Polymers with antimicrobial activity containing quaternary ammonium groups

2007264031-S1P receptor modulators for treating multiple sclerosis